Please Note: The Procurement Entity is “Health Canada” and the End user is “Public Health Agency Canada” .
The National Advisory Committee on Immunization (NACI) is an independent advisory body of experts in the fields of paediatrics, infectious diseases, immunology, medical microbiology, internal medicine and public health. The Committee reports to the Vice President, Infectious Disease Prevention and Control Branch (IDPCB), Public Health Agency of Canada (PHAC) and works with staff of the Centre for Immunization and Respiratory Infectious Diseases (CIRID).
NACI makes recommendations for the use of vaccines currently or newly approved for use in humans in Canada, including the identification of groups at risk for vaccine-preventable diseases for whom vaccination should be targeted. These recommendations include programmatic factors such as economics. NACI recommendations are published in advisory committee statements (http://www.phac-aspc.gc.ca/naci-ccni/index-eng.php#rec) as well as in the Canadian Immunization Guide (http://www.phac-aspc.gc.ca/publicat/cig-gci/index-eng…).
Within NACI, there are two working groups that oversee economic considerations. The Economics Task Group (ETG) is mandated to oversee and provide feedback on the development of economic processes and frameworks. The newly formed Economic Guidelines Task Group is mandated to develop economic guidelines to help standardize and facilitate the economic evaluation of vaccines in Canada.
The Contractor is to draft the economic guidance document under the direction of the Economic Guidelines Task Group. The guidelines are for economic evaluations of vaccines in Canada. Specifically, they will inform best practices for conducting and reporting economic evaluations.
